This trial is testing three different ways to detect neuroendocrine tumors, to see which is most effective.
1 Primary · 3 Secondary · Reporting Duration: 12 months after completion of the 68Ga-HA-DOTATATE, 18F-FDG, and investigational 18F-DOPA PET/CT scans
Awards & Highlights
1 Treatment Group
18F-DOPA PET/CT scan
1 of 1
50 Total Participants · 1 Treatment Group
Primary Treatment: 18F-DOPA with furosemide · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is the recruitment phase of this research still open?
"Right, the latest information from clinicaltrials.gov confirms that this experiment is currently searching for participants to join. It was first advertised on October 15th 2022 and was recently modified on November 16th 2022. This trial seeks 50 patients at a single facility." - Anonymous Online Contributor
What potential risks could arise from administering 18F-DOPA with furosemide to individuals?
"After carefully evaluating the Phase 2 trial data, our team at Power determined that 18F-DOPA with furosemide is safe and gave it a rating of 2." - Anonymous Online Contributor
How many volunteers are involved in this medical experiment?
"Affirmative. The clinical trial information displayed on clinicaltrials.gov confirms that this medical study, which was initially posted on October 15th 2022, is actively recruiting patients. Around 50 individuals need to be enlisted from a single centre." - Anonymous Online Contributor